




版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡介
Chapter36.
-lactamAntibiotics&OtherInhibitorsofCellWallSythesis
I.BETA-LACTAMCOMPOUNDS
Penicillins(青霉素類)Cepharosporins(頭孢菌素類)Cephamycins(頭霉素類)非典型-內(nèi)酰胺Carbapenems(碳青霉烯類)Monobectams(單環(huán)類)
Oxacephalosporins
(氧頭孢烯類)
-lactamaseinhibitors(
內(nèi)酰胺酶抑制劑)Theysharefeaturesofchemistry,mechanismofaction,pharmacologicandclinicaleffects,andimmunologiccharacteristicswithcephalosporins,monobactams,carbapenems,andbeta-lactamaseinhibitors,whichalsoarebeta-lactamcompounds.A.PENICILLINSTheattachmentofdifferentsubstitutents代替物to6-aminopenicillanicaciddeterminestheessentialpharmacologicandantibacterialpropertiesoftheresultingmolecules.Penicillinscanbeassignedtothebelowgroups.Naturalpenicilln-penicillinG.Thesehavethegreatestactivityagainstgram-positiveorganisms,gram-negativecocci,andnon-beta-lactamase-producinganaerobes厭氧菌andlittleactivityagainstgram-negativerods.Theyaresusceptibletohydrolysisbybeta-lactamases.ChemistryStructuralintegrityofthe6-aminopenicillanicacidnucleusisessentialforthebiologicactivityofthesecompounds.Ifthebeta-lactamringisenzymaticallycleavedbybacterialbeta-lactamases,theresultingproduct,penicilloicacid(青霉噻唑酸),lacksantibacterialactivity.However,itisanantigenic抗原的
determinantofthepenicillins,actingasasensitizingstructurewhenattachedtohostproteins.Productsofalkalinehydrolysisofthepenicillinsalsocontributetosensitization.TheprincipalclinicallimitationsofpenicillinGwereitsinstabilityatacidicpH,susceptibilitytodestructionbybeta-lactamase(penicillinase),anditsrelativeinactivityagainstgram-negativebacilli.Isolationofthenucleus,6-aminopenicillanicacid,allowedforthedevelopmentofnumeroussemisynthetic
penicillinsthatarestabletoacidpH,resistanttobeta-lactamase,andactiveagainstbothgram-positiveandgram-negativebacteria.PenicillinUnitsandFormulations
TheactivityofpenicillinGwasoriginallydefinedinunits.Crystallinesodiumpenicillincontainsapproximately1600units/mg(1unit=0.6μg;1millionunitofpenicillin=0.6g).Semisynthetic
penicillinsareprescribedbyweightratherthanunits.Mostpenicillinsaredispensed(調(diào)配)asthesodiumorpotassiumsaltofthefreeacid.Procainesaltsandbenzathine
(芐星)saltsofpenicillinGproviderepository(儲(chǔ)藏處)formsforintramuscularinjection.Indrycrystallineform,penicillinsaltsarestableforlongperiods(eg,foryearsat4℃).Solutionslosetheiractivityrapidly(eg,24hoursat20℃)andmustbepreparedfreshforadministration.Pharmacokinetics
PenicillinGisacid-instableandcannotbeenabsorbed.Administrationbytheintravenousrouteispreferredbecauseofirritationandlocalpainproducedbytheintramuscularinjectionoflargedoses.Lessprotein-boundproducehigherlevelsoffreedruginserum.PenicillinGiswidelydistributedinbodyfluidsandtissues.Theconcentrationsinmosttissuesareequaltothoseinserum.Theyarepolarmolecules,andtheconcentrationwithincellsislessthanthatinextracellularfluids.Penetrationintotheeye,theprostate,andthecentralnervoussystemispoor.However,withactiveinflammationofthemeninges,asinbacterialmeningitis,penicillinconcentrationsaresufficienttokillsusceptiblestrainsofpneumococciandmeningococci.Penicillinisrapidlyexcretedbythekidneyintotheurine;smallamountsarealsoexcretedintosputurn
(痰)andmilk.About10%ofrenalexcretionisbyglomerularfiltrationand90%bytubularsecretion.ThenormalhalflifeofpenicillinGisapproximately30minutes;renalfailure,itmaybeaslongas10hours.Benzathineandprocainepenicillinsareformulatedtodelayabsorption,resultinginprolongedbloodandtissueconcentrations.Thelatterissufficienttoprotectagainst預(yù)防
beta-hemolyticstreptococcalinfectionandtheformertotreatanestablishedinfectionwiththeseorganisms.Forpenicillinsthatareclearedbythekidney,thedosemustbeadjustedaccordingtorenalfunction.Becauseclearanceofpenicillinsislessefficientinthenewborn,dosesadjustedforweightalonewillresultinhighersystemicconcentrationsforlongerperiodsthanintheadult.MechanismofAction
Allbeta-lactamantibioticsinhibitbacterialgrowthbyinterferingwithaspecificstepinbacterialcellwallsynthesis.Thecellwallisarigidouterlayerthatcompletelysurroundsthecytoplasmicmembrane(Figure37-3).Itmaintainstheshapeofthecellandpreventscelllysisthatwouldoccurasaresultofthehighosmoticpressurewithinthecellcomparedtoitsexternalenvironment.Cellwalliscomposedofacomplexcross-linkedpolymer,peptidoglycan肽聚糖
(murein壁質(zhì),
mucopeptide粘肽),consistingofpolysaccharides多糖andpolypeptides.Thepolysaccharidecontainsalternatingaminosugars,N-acetylglucosamine(乙酰葡糖胺)
andN-acetylmuramicacid(乙酰胞壁酸)(Figure37-4).Afive-amino-acidpeptideislinkedtotheN-acetylmuramicacidsugar.ThispeptideterminatesinD-alanyl-D-alanine.Penicillin-bindingproteins(PBPs)catalyzethetranspeptidasereactionthatremovestheterminalalaninetoformacrosslinkwithanearbypeptide,whichgivescellwallitsstructuralrigidity.Beta-lactamantibioticsarestructuralanalogsofthenaturalD-Ala-D-AlasubstrateandtheyarecovalentlyboundbyPBPsattheactivesite.Afterabeta-lactamantibiotichasattachedtothePBP,thetranspeptidationreactionisinhibited(Figure37-5),peptidoglycansynthesisisblocked,andthecelldies.Theexactmechanismresponsibleforcelldeathisnotcompletelyunderstood,butautolysins(自溶素),bacterialenzymesthatremodelandbreakdowncellwall,areinvolved.Penicillinsandcephalosporinsarebactericidalonlyifcellsareactivelygrowingandsynthesizingcellwall.AntimicrobialactivityThepenicillin-susceptibleorganismsarenon-penicillinase-producingstrainsofmostcocci,gram-positivebacilli,spirochetesandactinomyces
(放線菌).ClinicalUses
Penicillinsarebyfarthemostwidelyeffectiveandthemostextensivelyusedantibiotics.Bloodlevelsofallpenicillinscanberaisedbysimultaneousadministrationofprobenecid,0.5g(10mg/kginchildren)every6hoursorally,whichimpairstubularsecretionofweakacidssuchasbeta-lactamcompounds.(1)PenicillinGisthedrugofchoiceforcocciinfectionscausedbystreptococci(pharyngitis咽炎,scarletfever,pneumonia,arthritis,endocarditis,etc.),meningococci,enterococci,Gonococci(淋球菌),
penicillin-susceptiblepneumococci,non-beta-lactamase-producingstaphylococci.PenicillinGwhenadministeredatdosesof18-24millionunitsisinhibitoryforenterococci,butthesimultaneousadministrationofanaminoglycosideisnecessarytoachieveabactericidaleffect,whichisrequiredwhentreatingenterococcal
endocarditis.BenzathinepenicillinandprocainepenicillinGforintramuscularinjectionyieldlowbutprolongeddruglevels.Asingleinjectionofbenzathinepenicillin,givenintramuscularly,issatisfactoryfortreatmentofbeta-hemolyticstreptococcalpharyngitis,syphilis(梅毒),andprophylaxisagainst預(yù)防
reinfectionwithbeta-hemolyticstreptococci.ProcainepenicillinG,whichinthepastwasusedfortreatinguncomplicatedpneumococcalpneumoniaorgonorrhea(淋病),israrelyusednowadaysbecausemanystrainsarepenicillin-resistant.(2)Gram-positivebacilliinfection:
Bacillusanthracis
(炭疽桿菌),clostridiumspecies(梭狀芽胞桿菌屬),andothergram-positiverodsandnon-beta-lactamase-producinggram-negativeanaerobicorganisms.(3)spirocheteinfections:
Treponema
pallidum
(蒼白密螺旋體),
Leptospira
(鉤端螺旋體
),Syphilis(梅毒),andtheinfectionsofmanyotherspirochetes.(4)actinomycesinfections:highdose,longperiod.ResistanceResistancetopenicillinsandotherbeta-lactamsisduetooneoffourgeneralmechanisms:(1)inactivationofantibioticbybeta-lactamase:Beta-lactamaseproductionisthemostcommonmechanismofresistance.Morethan100differentbeta-lactamaseshavebeenidentified.(2)modificationoftargetPBPs:Itisresponsibleformethicillin
(甲氧西林)resistanceinstaphylococciandpenicillinresistanceinpneumococci.TheseresistantorganismsproducePBPsthathavelowaffinityforbindingbeta-lactamantibiotics,andasaresulttheyarenotinhibitedexceptatrelativelyhighdrugconcentrations,whichmayexceedwhatisclinicallyachievable.(3)impairedpenetrationofdrugtotargetPBPs:Beta-lactamantibioticscrosstheoutermembraneandentergram-negativeorganismsviaoutermembraneproteinchannels(porins).Absenceoftheproperchannelordown-regulationofitsproductioncanpreventorgreatlyreducedrugentryintothecell.(4)thepresenceofaneffluxpump:Impairedpenetrationaloneisusuallynotsufficienttoconferresistance,becauseenoughantibioticeventuallyentersthecelltoinhibitgrowth.However,thisbarriercanbecomeimportantinthepresenceofabeta-lactamase,whichhydrolyzesantibioticasitslowlyentersthecell.Gram-negativeorganismsalsomayproduceaneffluxpump,whichconsistsofcytoplasmicandperiplasmicproteincomponents,thatefficientlytransportsomebeta-lactamantibioticsfromtheperiplasm外周胞質(zhì)(或壁膜間隙,是革蘭氏陰性菌的細(xì)胞膜與外膜之間的間隔區(qū)域)backacrosstheoutermembrane(eg,extrusion擠壓ofnafcillin萘夫西林
bySalmonellatyphimurium傷寒桿菌).AdverseReactions
(1)Hypersensitivereactions:
Thepenicillinsareremarkablynontoxic,thesafestofantibiotics.Mostoftheseriousadverseeffectsareduetohypersensitivity.
Allpenicillinsarecross-sensitizingandcross-reacting.Anypreparationcontainingpenicillin,includingfoodsorcosmetics(整容劑),mayinducesensitization.Symptomsofhypersensitivereactions(10%):itching(瘙癢),rashes,fever,serumsickness,angioneuroticedema.anaphylacticshock(5/10000).Ingeneral,sensitizationoccursindirectproportiontothedurationandtotaldoseofpenicillinreceivedinthepast.Theresponsibleantigenicdeterminantsaredegradationproductsofpenicillins,particularlypenicilloicacid青霉噻唑酸
andproductsofalkalinehydrolysis堿解boundtohostprotein.Thepreventionofandtreatmentofanaphylacticreactions:
Becauseofthepotentialforanaphylaxis,however,penicillinshouldbeadministeredwithcautionorasubstitutedruggivenifthereisahistoryofpenicillinallergy.Theincidenceofallergicreactionsinsmallchildrenisnegligible.①Inquirethehistoryofpenicillinallergicreaction:②
Cutaneoustest:③Theemergencymeasuresofanaphylacticshock:adrenaline0.5-1mg,subcutaneousorintramuscularinjection.Mostpatientsallergictopenicillinscanbetreatedwithalternativedrugs.However,ifnecessary(eg,treatmentofenterococcal
endocarditisorneurosyphilis神經(jīng)梅毒inahighlypenicillin-allergicpatient),desensitizationcanbeaccomplishedwithgraduallyincreasingdosesofpenicillin.(2)Otheradversereactions:phlebitis靜脈炎
(i.v.);injectionsiteinflammatoryreactions(i.m);degeneration變性
ofnervetissue;andcentralnervoussystemexcitability.Inpatientswithrenalfailure,penicillininhighdosescancauseseizures.
Herxheimerreaction(赫氏反應(yīng)):Thetreatmentofsyphilis,spirochete,etc.Thesymptomsisexacerbed.Semisynthetic
penicillins1.Pencillinsfororaladministrition(Thegastricacid-resistantPenicillins):
Phenoxymethylpenicillin
(苯氧甲基青霉素,PenicillinV).
(1)Theoralformofpenicillin.(2)resistanttogastricacid,wellabsorbed(60%)whenitisgivenonanemptystomach.Thehalf-lifeislongerthanpenicillinG.AsatisfactorysubstituteforPenicillinGagainstgonorrhoea淋病andmeningococcalmeningitis.(3)PenicillinVisindicatedonlyinminorinfectionsbecauseofitsrelativelypoorbioavailability.2.ThePenicillinase-resistantPenicillins:
Methicillin(甲氧西林),Oxacillin(苯唑西林),Cloxacillin(氯唑西林),Dicloxacillin(雙氯西林),Nafcillin
(萘夫西林),etc.①stableinanacidicmedium;②resistanttocleavagebypenicillinase;③Thesepenicillinsareresistanttostaphylococcalbeta-lactamases.Theyareactiveagainststaphylococciandstreptococcibutinactiveagainstenterococci,anaerobicbacteria,andgram-negativecocciandrods.usefortreatmentofPenicillinG-resistantstaphylococciinfection.④Nafcillinisprimarilyclearedbybiliaryexcretion,andoxacillin苯唑西林,dicloxacillin雙氯西林,andcloxacillin氯唑西林areeliminatedbyboththekidneyandbiliaryexcretion,thus,nodosageadjustmentisrequiredforthesedrugsinrenalfailure.3.BroadspectrumPenicillins(Extended-spectrumpenicillins):
Amipicillin
(氨芐西林),Carbenicillin(羧芐西林),Piperacillin(哌拉西林),etc.①havesimilarantibacterialactivityandabroaderspectrum;②alldestroyedbyβ-lactamase.(1)Ampicillin
(氨芐西林),Amoxicillin(阿莫西林):
Thesedrugsretaintheantibacterialspectrumofpenicillinandhaveimprovedactivityagainstgram-negativeorganisms,buttheyaredestroyedbybeta-lactamases.Pseudomonasaeruginosa-resistanceTherapeuticApplications:Upperrespiratoryinfections;Urinarytractinfections;Meningitis;Salmonellainfections.(2)Carbenicillin(羧芐西林),
Ticarcillin(替卡西林):
belongtotheantipseudomonal
penicillins.WithactivityagainstPseudomonasaeruginosa
andsomeProteus(變形桿菌屬).(3)Piperacillin(哌拉西林)Mezlocillin
(美洛西林):Hasthebroadestantibacterialspectrumandthemostactivityofthepenicillins,withactivityagainstPseudomonasaeruginosaetc.TherapeuticApplications:Forthetreatmentofthepatientswithsevereinfectioncausedbygram-negativebacteria,usuallyincombinationwithaminoglycosides.(4)Mecillinam(美西林),
ivmecillinam(匹美西林),
emocillin(替莫西林),
ormidacillin(福米西林),etc.Anti-gram-negativebacillipenicillins.B.CEPHALOSPORINS
Cephalosporinsaresimilartopenicillinschemically,inmechanismofaction,andtoxicity.Cephalosporinsaremorestablethanpenicillinstomanybacterialbeta-lactamasesandthereforeusuallyhaveabroaderspectrumofactivity.ChemistryThenucleusofthecephalosporins,7-aminocephalosporanicacid.bearsacloseresemblanceto6-aminopenicillanicacid.TheyaresolubleinwaterandrelativelystabletopHandtemperaturechanges.ClassificationThewell-acceptedsystemofclassificationby“generations”isbasedongeneralfeaturesofantimicrobialactivity.Cephalosporinscanbeclassifiedintofourmajorgroupsorgenerations,dependingmainlyonthespectrumofantimicrobialactivity.Asageneralrule,first-generationcompoundshavebetteractivityagainstgram-positiveorganismsandthelatercompoundsexhibitimprovedactivityagainstgram-negativeaerobicorganisms.1.FIRSTGENERATIONCEPHALOSPORINS
Thisgroupincludescefadroxil
(頭孢羥氨芐),
cefazolin
(頭孢唑林),
cephalexin
(頭孢氨芐),
cephalothin
(頭孢菌素),
cephapirin
(頭孢吡硫),andcephradine
(頭孢拉啶).Thesedrugsareveryactiveagainstgram-positivecocci,includingpneumococci,streptococci,andstaphylococci.Cephalosporinsarenotactiveagainstmethicillin-resistantstrainsofstaphylococci.Pharmacokinetics
(1)Oral(cephalexin
頭孢氨芐,
cephradine頭孢拉啶,andcefadroxil頭孢羥氨芐):Urineconcentrationisusuallyveryhigh.Excretionismainlybyglomerularfiltrationandtubularsecretionintotheurine.Tubularsecretoryblockingagents,eg,probenecid,mayincreaseserumlevelssubstantially.Inpatientswithimpairedrenalfunction,dosagemustbereduced(Table37-2).(2)Parenteral:Afteranintravenousinfusionof1g,thepeaklevelofcefazolin頭孢唑林
is90-120pg/mL.Cefazolincanalsobeadministeredintramuscularly.Excretionisviathekidney,anddoseadjustmentsmustbemadeforimpairedrenalfunction.ClinicalUses
(1)Oraldrugsmaybeusedforthetreatmentofurinarytractinfections,forminorstaphylococcallesions,orforminorpolymicrobialinfectionssuchascellulitis
(蜂窩織炎)orsofttissueabscess.However,oralcephalosporinsshouldnotberelieduponinserioussystemicinfections.(2)Cefazolinpenetrateswellintomosttissues.Itisthedrugofchoiceforsurgicalprophylaxis.Cefazolindoesnotpenetratethecentralnervoussystemandcannotbeusedtotreatmeningitis.Cefazolinisanalternativetoanantistaphylococcalpenicillinforpatientswhoareallergictopenicillin.2.SECOND-GENERATIONCEPHALOSPORINS
Membersofthisgroupincludecefaclor頭孢克洛,cefamandole頭孢孟多,cefonicid頭孢尼西,cefuroxime頭孢呋新,cefprozil頭孢羅齊,loracarbef羅拉卡貝
andceforanide頭孢雷特andthestructurallyrelatedcephamycins頭霉素類
cefoxitin頭孢西丁,cefmetazole頭孢氰唑,cefotetan頭霉雙硫唑,whichhaveactivityagainstanaerobes.
Ingeneral,theyareactiveagainstorganismsaffectedbyfirst-generationdrugs,buttheyhaveanextendedgram-negativecoverage范圍.Allsecond-generationcephalosporinsarelessactiveagainstgram-positivebacteriathanthefirst-generationdrugs.Pharmacokinetics
(1)Oral:
Cefaclor頭孢克洛,cefuroxime頭孢呋新,cefprozil頭孢羅齊,andloracarbef羅拉卡貝canbegivenorally.(2)Parenteral:
Therearemarkeddifferencesamongdrugsinhalf-life,proteinbinding,andintervalbetweendoses.Ingeneral,intramuscularinjectionistoopainfultobeused.Inrenalfailure,dosageadjustmentsarerequired(Table37-2).
ClinicalUses
Theoralsecond-generationcephalosporinsareactiveagainstbeta-lactamase-producingHinfluenzae
(流感嗜血桿菌)orBranhamella
catarrhalis
(卡他菌屬)andhavebeenprimarilyusedtotreatsinusitis鼻竇炎,otitis耳炎,orlowerrespiratorytractinfections,inwhichtheseorganismshaveanimportantrole.
Becauseoftheiractivityagainstanaerobes(includingBfragilis脆弱類桿菌),cefoxitin頭孢西丁,cefotetan頭霉雙硫唑,orcefmetazole頭孢氰唑canbeusefulinsuchmixedanaerobicinfectionsasperitonitis(腹膜炎)ordiverticulitis(憩室炎).
3.THIRD-GENERATIONCEPHALOSPORINS
Includingcefoperazone頭孢哌酮,cefotaxime頭孢噻肟,ceftazidime頭孢他啶,ceftizoxime頭孢唑肟,ceftriaxone頭孢曲松,cefrxime,cefpodoxime(proxetil頭孢泊肟酯),ceftibuten頭孢布坦,andmoxalactam羥羧氧酰胺菌素.Themajorfeaturesofthesedrugs(exceptcefoperazone)aretheirexpandedgram-negativecoverageandtheabilityofsometocrosstheblood-brainbarrier.Pharmacokinetics
Theypenetratebodyfluidsandtissueswellandachievelevelsinthecerebrospinalfluidsufficienttoinhibitmostpathogens,includinggram-negativerods.Thehalt-livesandthenecessarydosingintervalsvarygreatly.Theexcretionofcefoperazone頭孢哌酮andceftriaxone頭孢曲松ismainlythroughthebiliarytract,andnodosageadjustmentisrequiredinrenalinsufficiency.Theothersareexcretedbythekidneyandthereforerequiredosageadjustmentinrenalinsufficiency.ClinicalUses
Third-generationcephalosporinsareusedtotreatawidevarietyofseriousinfectionscausedbyorganismsthatareresistanttomostotherdrugs.Becauseoftheirpenetrationofthecentralnervoussystem,third-generationcephalosporinscanbeusedtotreatmeningitis.Otherpotentialindicationsincludeempiricaltherapyofsepsisofunknowncauseinboththeimmunocompetent
(免疫活性)andtheimmunocompromised
(免疫受損)patientandtreatmentofinfectionsforwhichacephalosporinistheleasttoxicdrugavailable.4.FOURTH-GENERATIONCEPHALOSPORINS
Cefepime
(頭孢吡肟),isinmanywayssimilartothird-generationagents,butitismoreresistanttohydrolysisbychromosomalbeta-lactamasesandsomeextended-spectrumbeta-lactamasesthatinactivatemanyofthethird-generationcephalosporins.IthasgoodactivityagainstPaeruginosa銅綠假單胞菌,
Enterobacteriaceae(腸桿菌科),
Saureus(金葡菌),andSpneumoniae(肺炎球菌).Itishighlyactiveagainsthaemophilus嗜血桿菌屬andneisseria奈瑟氏菌屬.Unlikeceftazidime
頭孢他啶,however,cefepimehasgoodactivityagainstmostpenicillin-resistantstrainsofstreptococci,anditmaybeusefulintreatmentofenterobacterinfections.Otherwise,itsclinicalroleissimilartothatofthird-generationcephalosporins.5.ADVERSEEFFECTSOFCEPHALOSPORINS
(1)Allergy:Cephalosporinsaresensitizingandmayelicitavarietyofhypersensitivityreactionsthatareidenticaltothoseofpenicillins,includinganaphylaxis,fever,skinrashes,nephritis,granulocytopenia,andhemolyticanemia.However,thechemicalnucleusofcephalosporinsissufficientlydifferentfromthatofpenicillinssothatsomeindividualswithahistoryofpenicillinallergymaytoleratecephalosporins.Thefrequencyofcross-allergenicitybetweenthetwogroupsofdrugsprobablyisaround5-10%.However,patientswithahistoryofanaphylaxistopenicillinsshouldnotreceivecephalosporins.(2)Toxicity:Localirritationcanproduceseverepainafterintramuscularinjectionandthrombophlebitis血栓性靜脈炎
afterintravenousinjection.Renaltoxicity,includinginterstitialnephritisandeventubularnecrosis,andhascausedthewithdrawalofcephaloridine
(頭孢噻啶).Cephalosporinsthatcontainamethylthiotetrazole甲硫基四氮唑group(eg,cefamandole
頭孢孟多,moxalactam
羥羧氧酰胺菌素,cefmetazole
頭孢氰唑,cefotetan
頭霉雙硫唑,cefoperazone
頭孢哌酮)frequentlycausehypoprothrombinemia
(低凝血酶原血癥)andbleedingdisorders.AdministrationofvitaminKcanpreventthis.Drugswiththemethylthiotetrazoleringcanalsocauseseveredisulfiram-like戒酒硫(雙硫侖)樣反應(yīng)reactions;consequently,alcoholandalcohol-containingmedicationsmustbeavoided.
(3)Superinfection:Manysecond-andparticularlythird-generationcephalosporinsareineffectiveagainstgram-positiveorganisms,especiallymethicillin-resistantstaphylococciandenterococci.Duringtreatmentwithsuchdrugs,theseresistantorganisms,aswellasfungi,oftenproliferateandmayinducesuperinfection.II.OTHERBETA-LACTAMDRUGS
1.Cephamycins
(頭霉素類)Itisfermentation發(fā)酵productsofstreptomyces
(鏈霉菌屬)andsometotallysyntheticdrugssuchasmoxalactam
(頭孢西丁)
resemblecephalosporins.Ithasthesimilarantibacterialactivityandspectrumtothe2ndgeneration
Cepharosporins.Forthetreatmentofanaerobicinfections.2.MONOBACTAMS(單環(huán)類)Aztreonam
(氨曲南),
Carumonam
(卡蘆莫南):Thesearedrugswithamonocyclicbeta-lactamring.Theyarerelativelyresistanttobeta-lactamasesandactiveagainstgram-negativerods.Theyhavenoactivityagainstgram-positivebacteriaoranaerobes.Aztreonam
(氨曲南)isamonobactam,resemblesaminoglycosidesinitsspectrumofactivity.Belongstonarrow-spectrumantibiotic.Thehalf-lifeis1-2hoursandisgreatlyprolongedinrenalfailure.Forthetreatmentofaerobicgram-negativebacilliinfections.Penicillin-allergicpatientstolerateaztreonamwithoutreaction.Occasionalskinrashesandelevationsofserumaminotransferasesoccurduringadministrationofaztreonam,butmajortoxicityhasnotyetbeenreported.3.BETA-LACTAMASEINHIBITORS
Clavulanicacid(克拉維酸),
Sulbactam
(舒巴坦)&Tazobactam
(三唑巴坦):Bindingtoβ-lactamasesandinactivatethem,thuspreventingthedestructionofβ-lactamantibioticsthataresubstratesfortheseenzyme.Thesesubstancesresemblebeta-lactammoleculesbutthemselveshaveveryweakantibacterialaction.Theyarepotentinhibitorsofmanybutnotallbacterialbeta-lactamasesandcanprotecthydrolyzable
penicillinsfrominactivationbytheseenzymes.Beta-lactamaseinhibitorsaremostactiveagainstAmblerclassAbeta-lactamases.TheyarenotgoodinhibitorsofclassCbeta-lactamases.Beta-lactamaseinhibitorsareavailableonlyinfixedcombinationswithspecificpenicillins.Theantibacterialspectrumofthecombinationisdeterminedbythecompanionpenicillin,notthebeta-lactamaseinhibitor.Theindicationsforpenicillin-beta-lactamaseinhibitorcombinationsareempiricaltherapyforinfectionscausedbyawiderangeofpotentialpathogensinbothimmunocompromised
(免疫受損)andimmunocompetent
(免疫活性)patientsandtreatmentofmixedaerobicandanaerobicinfections,suchasintra-abdominalinfections.Adjustmentsforrenalinsufficiencyaremadebasedonthepenicillincomponent.4.CARBAPENEMS
Thecarbapenems
(碳青霉烯類)arestructurallyrelatedtobeta-lactamantibiotics(Imipenem亞胺培南
andmeropenem(美洛培南).Imipenemhasawidespectrumwithgoodactivityagainstmanygram-negativerods,gram-positiveorganisms,andanaerobes.Itisresistanttomostbeta-lactamasesbutnotmetallo-beta-lactamases.Imipenemisinactivatedbydehydropeptidases氫肽酶(dipeptidase二肽酶)inrenaltubules,resultinginlowurinaryconcentrations.Consequently,itisadministeredtogetherwithcilastatin西司他丁
whichinhibitsthedegradationofimipenembyarenaltubulardipeptidase,forclinicaluse.Meropenem美洛培南issimilartoimipenembuthasslightlygreateractivityagainstgram-negativeaerobesandslightlylessactivityagainstgram-positives.Itisnotsignificantlydegradedbyrenaldehydropeptidaseanddoesnotrequireaninhibitor.Imipenempenetratesbodytissuesandfluidswell,includingthecerebrospinalfluid.Thedosemustbereducedinrenalinsufficiency.Meropenemalsopenetrateswellintotissuesandcerebrospinalfluid.Imipenemormeropenemisindicatedforinfectionscausedbysusceptibleorganismsthatareresistanttootheravailabledrugs.Pseudomonasmayrapidlydevelopresistancetoimipenem,sosimultaneoususeofanaminoglycosideisrecommendedforinfectionscausedbytheseorganisms.Imipenemormeropenemwithorwithoutanaminoglycosidemaybeeffectivetreatmentforfebrile(發(fā)熱性)
neutropenic中性白細(xì)胞減少癥patients.Themostcommonadverseeffectsofimipenemarenausea,vomiting,diarrhea,skinrashes,andreactionsattheinfusionsites.Excessivelevelsinpatientswithrenalfailuremayleadtoseizures.Meropenemislesslikelytocauseseizuresthanimipenem.Patientsallergictopenicillinsmaybeallergictocarbapenemsaswell.5.
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- GB/T 25246-2025畜禽糞肥還田技術(shù)規(guī)范
- 2025年常德c1貨運(yùn)從業(yè)資格證考試內(nèi)容
- 兒童桌子采購合同范本
- 鄉(xiāng)鎮(zhèn)飯店轉(zhuǎn)讓合同范本
- 公司房租轉(zhuǎn)租合同范本
- 倉庫裝修合同范本版
- 上海廠房出售合同范本
- 茶器定制合同范本
- 中標(biāo)咨詢合同范本
- 農(nóng)村訂購混泥土合同范本
- 2023年中國農(nóng)業(yè)大學(xué)人才招聘筆試真題
- GB/T 44619-2024福壽螺檢疫鑒定方法
- 2024年湖南省公務(wù)員錄用考試《行測》試題及答案解析
- 北京聯(lián)合大學(xué)《電子技術(shù)基礎(chǔ)》2022-2023學(xué)年期末試卷
- 電力工程質(zhì)量驗(yàn)收手冊
- 四年級(jí)語文下冊 期末復(fù)習(xí)文言文閱讀專項(xiàng)訓(xùn)練(一)(含答案)(部編版)
- 學(xué)習(xí)新課程標(biāo)準(zhǔn)的方案
- 2024年知識(shí)競賽-煙花爆竹安全管理知識(shí)競賽考試近5年真題附答案
- 民航基礎(chǔ)知識(shí)應(yīng)用題庫100道及答案解析
- 2024年黑龍江省哈爾濱市中考數(shù)學(xué)試卷(附答案)
- SolidWorks-2020項(xiàng)目教程全套課件配套課件完整版電子教案
評(píng)論
0/150
提交評(píng)論